Delivery Order SPE2DR25D2014-SPE2DR26FZ89K
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,675.10 to AmerisourceBergen Drug Corp for the supply of Tresiba FlexTouch 100 Unit/mL 3mL insulin pens. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 10, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs across military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $1,061.59 to AmerisourceBergen Drug Corp for Tresiba FlexTouch 100 Unit/ML 3ML insulin pens. This was a competitively awarded, non-set-aside firm fixed price contract with an ultimate completion date of September 26, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $16,628.59 to AmerisourceBergen Drug Corp for Tresiba FlexTouch 200 Unit/mL 3mL insulin pens. This competitively awarded, non-set-aside contract uses firm fixed pricing and is scheduled for completion by December 11, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,801.04 to AmerisourceBergen Drug Corp for Tresiba FlexTouch 100 Unit/ML 3ML insulin pens, with an ultimate completion date of December 4, 2025. This non-competitive delivery order was issued under a firm fixed price arrangement and represents a single pharmaceutical supply transaction supporting federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,607.96 to AmerisourceBergen Drug Corp for Tresiba FlexTouch 200 Unit/ML 3ML insulin pens. This competitively awarded, non-set-aside contract was issued on December 15, 2025, with an ultimate completion date of December 16, 2025, and represents a firm fixed price delivery order for pharmaceutical supplies to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $1,038.15 to AmerisourceBergen Drug Corp for Tresiba FlexTouch 100 Unit/ML 3ML insulin pens. This competitive award, issued on September 29, 2025, with an ultimate completion date of September 30, 2025, represents a firm fixed price transaction for pharmaceutical supply to support federal medical procurement needs. The contract specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $1,211.75 delivery order to AmerisourceBergen Drug Corp for Tresiba FlexTouch 200 Unit/ML 3ML insulin pens. This firm fixed price, non-competitive delivery order was issued on September 26, 2025, with an ultimate completion date of September 29, 2025. The order was fulfilled at the vendor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency awarded a $6,736.43 delivery order to AmerisourceBergen Drug Corp for Tresiba FlexTouch 200 Unit/mL 3mL insulin pens, with an ultimate completion date of October 27, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $2,640.04 to AmerisourceBergen Drug Corp for the supply of Tresiba FlexTouch 100 Unit/mL 3mL insulin pens. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by July 30, 2025. The contract will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,714.30 to AmerisourceBergen Drug Corp for Tresiba FlexTouch 100 Unit/ML 3ML insulin pens. This competitively awarded, firm fixed-price delivery order was issued on April 30, 2025, with an ultimate completion date of May 1, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen Drug Corp maintains its corporate headquarters and serves as a major vendor for federal...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FZ89KDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,340.08 to AmerisourceBergen Drug Corp for Tresiba FlexTouch 100 Unit/ML 3ML insulin pens. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of December 8, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The order will be fulfilled from the company's Conshohocken facility. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs, including products for the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen Drug Corp was competitively awarded this IDC based on its demonstrated capability to meet federal procurement requirements and maintain a robust pharmaceutical supply chain for the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 12/4/25 |